Intech Financial Statements From 2010 to 2024
| 6461 Stock | TWD 27.65 0.35 1.25% |
Check Intech Biopharm financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intech Biopharm's main balance sheet or income statement drivers, such as , as well as many indicators such as . Intech financial statements analysis is a perfect complement when working with Intech Biopharm Valuation or Volatility modules.
Intech |
Intech Biopharm Company Shares Outstanding Analysis
Intech Biopharm's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Intech Biopharm Shares Outstanding | 116.96 M |
Most of Intech Biopharm's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intech Biopharm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Intech Biopharm has 116.96 M of shares currently outstending. This is 35.22% lower than that of the Healthcare sector and 9.45% higher than that of the Biotechnology industry. The shares outstanding for all Taiwan stocks is 79.55% higher than that of the company.
Intech Biopharm Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Intech Biopharm's current stock value. Our valuation model uses many indicators to compare Intech Biopharm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Intech Biopharm competition to find correlations between indicators driving Intech Biopharm's intrinsic value. More Info.Intech Biopharm is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Intech Biopharm's earnings, one of the primary drivers of an investment's value.About Intech Biopharm Financial Statements
Intech Biopharm investors use historical fundamental indicators, such as Intech Biopharm's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Intech Biopharm. Please read more on our technical analysis and fundamental analysis pages.
Pair Trading with Intech Biopharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Intech Biopharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intech Biopharm will appreciate offsetting losses from the drop in the long position's value.Moving together with Intech Stock
| 0.85 | 4743 | Oneness Biotech | PairCorr |
| 0.87 | 6547 | Medigen Vaccine Biologics | PairCorr |
| 0.82 | 4174 | OBI Pharma | PairCorr |
Moving against Intech Stock
| 0.73 | 1449 | Chia Her Industrial Split | PairCorr |
| 0.72 | 2609 | Yang Ming Marine | PairCorr |
| 0.61 | 4162 | PharmaEngine | PairCorr |
| 0.54 | 0050 | YuantaP shares Taiwan | PairCorr |
| 0.46 | 0057 | Fubon MSCI Taiwan | PairCorr |
The ability to find closely correlated positions to Intech Biopharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Intech Biopharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Intech Biopharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Intech Biopharm to buy it.
The correlation of Intech Biopharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Intech Biopharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Intech Biopharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Intech Biopharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Intech Stock Analysis
When running Intech Biopharm's price analysis, check to measure Intech Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intech Biopharm is operating at the current time. Most of Intech Biopharm's value examination focuses on studying past and present price action to predict the probability of Intech Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intech Biopharm's price. Additionally, you may evaluate how the addition of Intech Biopharm to your portfolios can decrease your overall portfolio volatility.